| Ticker: | MBOT |
| Current Price: | $0.98 |
| % Daily Change: | -4.98% |
| Volume (1,000s): | 867.09 |
| Average Volume (1,000s): | 1,238.40 |
| Market Cap (M): | $65.73 |
| 1/2/2024 Price: | $1.33 |
| Change Since Inception: | -26.32% |
25 Recreation Park Drive
Unit 108
Hingham, MA 02043
United States
Microbot Medical Inc., a pre-clinical medical device company, researches, designs, and develops micro-robotics assisted medical technologies targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable self-propelled locomotive device to treat capabilities within tubular lumens, such as the blood vessels, respiratory, and the urinary and GI tracts; a combination of a guidewire and microcatheter technologies that are used for endoluminal surgery; and maneuver guidewire, microcatheters, and over-the-wire devices within the body’s vasculature. It has 37 issued/allowed patents and 15 patent applications pending worldwide. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.